Evaxion Biotech ( (EVAX) ) has provided an update.
Evaxion Biotech A/S has announced its Articles of Association, focusing on the issuance of warrants and potential capital increases. The board is authorized to issue warrants and increase share capital up to a nominal value of DKK 9,461,540, aligning with their strategic goals to enhance shareholder value and operational flexibility.
More about Evaxion Biotech
Evaxion Biotech A/S is a biotechnology company that specializes in creating advanced software to develop novel immune therapies and vaccines. It operates under the secondary name NovVac A/S.
YTD Price Performance: 2.81%
Average Trading Volume: 342,920
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.14M
See more data about EVAX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com